A seven-school university with branches throughout West Texas in Abilene, Amarillo, El Paso, Dallas, Midland/Odessa, and Lubbock, the Texas Tech University Health Science Center (TTUHSC) has trained more than 10,000 medical professionals while providing quality care to over 2.5 million people. As a major research university, the TTUHSC’s professionals study multiple areas, including cancer, rural health, aging, and reproduction. The university is a key piece of the region’s overall access to medical care, with its graduates making up more than 20% of West Texas’ physicians.The TTUHSC began in 1969 as the Texas Tech University School of Medicine and took its current name in 1979. The new name came with additional administrative changes that later led to the School of Nursing, the Graduate School of Biomedical Sciences, and the School of Pharmacy. In 2003, an additional medical school, now called the Paul L. Foster School of Medicine, was established in El Paso and earned full accreditation in 2008.Dr. Chendil Damodaran serves as an Associate Professor of Medicine at TTUHSC in El Paso, Texas. With more than 15 years of experience, Dr. Chendil Damodaran graduated from the University of Madras with a Ph.D. in Environmental Toxicology in 1995.
With an extensive background in the health sciences, Professor Chendil Damodaran, Ph.D., has dedicated her career to the field of hematology and oncology. Professor Chendil Damodaran is a graduate of the University of Madras, holding a Doctor of Philosophy and a Master of Science in Environmental Toxicology, as well as a Bachelor of Science in Zoology. Professor Damodaran's professional experience began in 1993, when she served the Research Institute for Nuclear Medicine and Biology of Hiroshima University as a Foreign Research Fellow in the Department of Hematology. Her degree in environmental toxicology also led her to the Frederick Institute of Plant Protection and Toxicology in Chennai, India, where she served as a Research Associate in the Department of Toxicology. In 1995, interested in genetics, Professor Damodaran obtained a position as Senior Research Officer at Sri Ramachandra Medical College, leading the Department of Genetic Research. Following the receipt of her doctoral degree, Professor Chendil Damodaran became a Research Associate of the University of Kentucky, performing research in the Department of Radiation Medicine. Professor Damodaran remained with the University of Kentucky and the Department of Radiation Medicine for several years, later moving on to the position of Scientist-III. By 2003, she was appointed to the position of Research Assistant Professor, serving the Division of Clinical and Reproductive Science of the Department of Clinical Sciences, where she received a promotion to Assistant Professor in 2007. Presently, Professor Chendil Damodaran is in the process of publishing a book on a nontoxic therapy for prostate cancer, for which she received $75,000 of funding from the Trivedi Foundation. Her most recent accomplishments include her appointment to Associate Professor of the Paul L. Foster School of Medicine at the Texas Tech University Health Sciences Center, a position she currently holds.